SAN FRANCISCO -- For patients with recurrent prostate cancer, those with a certain subtype had clinically meaningful benefits when apalutamide (Erleada) was added to salvage radiotherapy after radical ...

SAN FRANCISCO -- Men with advanced prostate cancer and limited metastatic recurrence lived more than twice as long without disease progression when they received metastasis-directed radioactive ...

The best-selling author and TV personality shared details about being diagnosed with prostate cancer in 2024, and his fight to be cancer-free ...

Johnny Ball has revealed that he has been suffering from prostate cancer. The 87-year-old broadcaster, best known for presenting the children’s series Play School on the BBC, said that he had ...

For patients with intermediate-risk, localized prostate cancer, radiation therapy delivered in five sessions reduced patient-reported side effects compared to longer courses of radiation, according to ...

The global hormone sensitive advanced prostate cancer (HSPC) market is witnessing substantial growth due to rising prostate cancer cases, advancements in hormonal and combination treatments, and ...

For patients with intermediate-risk, localized prostate cancer, radiation therapy delivered in five sessions reduced patient-reported side effects compared to longer courses of radiation, according to ...

A Jamaican urologist is urging a shift in the focus of prostate cancer screening from the long-promoted digital rectal examination (DRE) to the prostate-specific antigen (PSA) blood test, citing what ...

Scientists use a metric called “area under the curve” or AUC to assess how well the test performed. An AUC of 1 is a perfect test; an AUC of 0.5 is like a coin toss. In the first group of 243 men, ...

Johnny Ball says it is "great to still be here" after his secret prostate cancer battle. The 87-year-old TV legend was diagnosed with the disease in August 2022 during an annual blood test when ...

Use of PSMA PET/CT imaging before salvage radiotherapy was linked to improved survival for patients with BCR prostate cancer after radical prostatectomy ...

The agreement includes the transfer of regulatory dossiers, manufacturing competencies and technical support to enable GE HealthCare to drive clinical development in Japan, towards potential ...